What are the side effects of canakinumab?

Canakinumab(Canakinumab) is an interleukin inhibitor suitable for the treatment of cr Yopyrinassociated periodic syndromes (CAPS), including familial old autoinflammatory syndrome and Markle-Wells syndrome in adults and children. It is suitable for the treatment of tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) in adult and pediatric patients. Indicated for the treatment of hyperimmune globulinD (hyperIgD) syndrome (HIDS in adults and children) ) (HIDS) /Mevalonate kinase deficiency (MKD). Indicated for the treatment of familial Mediterranean fever (FMF) in adults and children. Indicated for adults with gout attacks who are contraindicated, intolerant, or ineffective of NSAIDs and colchicine and who are not suitable for repeated courses of corticosteroids.

Common side effects of canakinumab include nasopharyngitis (34%), diarrhea (20%), influenza (17%), rhinitis (17%) span>, Headache (14%), Nausea (14%), Dizziness (9-14%), Gastroenteritis (11%), Pharyngitis (11%), Weight gain (11%), Tracheitis (11%), Musculoskeletal pain (11%), pain at the injection site (9%), thrombocytopenia (6.3%), aspartate aminotransferase/increased alanine aminotransferase (4.1%), etc.

Before starting canakinumabtreatment, your doctor may do tests to make sure you don't have tuberculosis or other infections. Canakinumab is injected under the skin, and medical staff will inject the drug into the patient. Canakinumab is usually given every 4 to 8 weeks, depending on the condition being treated, as directed by your doctor. Tell your doctor if you have any changes in your weight. Canakinumab dosage is based on weight (especially in children and adolescents) and any changes may affect the dosage. Canakinumab can weaken the patient's immune system and the patient's blood may need to be tested frequently. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.